Review of statistical methods for analysing healthcare resources and costs

Cited by (678)

Items 401–500 of 678

1. The management of small area burns and unexpected illness after burn in children under five years of age - A costing study in the English healthcare setting.
   R. Kandiyali, J. Sarginson, L. Hollén, F. Spickett-Jones, Amber Young · 2017 · Burns
2. The modeling of medical expenditure data from a longitudinal survey using the Generalized Method of Moments (GMM) approach
   Z. Hass, M. Levine, L. Sands, Jeffrey Ting, Hui-Ping Xu · 2016 · Statistics in Medicine
3. Heterogeneous effect of coinsurance rate on healthcare expenditure: generalized finite mixtures and matching estimators
   G. Besstremyannaya · 2015 · Applied Economics
4. Can increases in CHIP copayments reduce program expenditures on prescription drugs?
   B. Sen, Justin Blackburn, M. Morrisey, D. Becker, M. Kilgore, C. Caldwell, N. Menachemi · 2014 · Health Care Financing Review
5. Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods
   M. Sadatsafavi, C. Marra, S. Aaron, S. Bryan · 2012 · Trials
6. Healthcare Costs and Trends of Multimorbidity in COPD Patients: A Population-Based Study in Singapore
   Y. R. Juang, L. Lim, S. Chotirmall, J. Abisheganaden, M. Koh, Ming-Ju Tsai, Mei Fong Liew, A. Yii, P. Y. Tiew, David B. Price et al. · 2026 · International Journal of COPD
7. The associations between multimorbidity, healthcare resource utilisation and costs in individuals with Alzheimer's disease dementia
   Sophie Edwards, Marc Evans, Craig William Ritchie, Julie Hviid Hahn‐Pedersen, Mei Sum Chan, Benjamin Bray, Alice Clark, Christian Ahmad Wichmann, Dominic Trépel · 2025 · Aging and Health Research
8. Lifestyle and Cardiometabolic Risk Factors Associated with Impoverishment Due to Out-of-Pocket Health Expenditure in São Paulo City, Brazil
   L. Trindade, J. Pereira, J. Leite, M. Rogero, R. Fisberg, F. Sarti · 2024 · International Journal of Environmental Research and Public Health
9. A Monte Carlo simulation-based simulated annealing algorithm for predicting the minimum staffing requirement at a blood donor centre
   Achini Wellalage, M. Fackrell, Le-Le Zhang · 2023 · Annals of Operations Research
10. Healthcare expenditure and its socio-demographic and clinical predictors in Australians with poorly controlled asthma
    Stella T. Lartey, Thomas Wai-Chun Lung, Sarah Serhal, Lre Bereznicki, Bonnie Jayne Bereznicki, Lynne Emmerton, Sinthia Z. Bosnic-Anticevich, Bandana Saini, Laurent Billot, Ines Krass et al. · 2023 · PLoS ONE
11. Who is eating quinoa?: How consumer characteristics and beliefs affect the expenditure on this functional food versus traditional staple items
    L. Emilio Morales, Angie Higuchi · 2021 · Journal of Sensory Studies
12. Clinical and economic outcomes attributable to carbapenem-resistant Enterobacterales and delayed appropriate antibiotic therapy in hospitalized patients
    Kirati Kengkla, Yuttana Wongsalap, Natthaya Chaomuang, Pichaya Suthipinijtham, Peninnah Oberdorfer, Surasak Saokaew · 2021 · Infection Control and Hospital Epidemiology
13. Hybrid model for a cross‐department efficiency evaluation in healthcare systems
    M. Hasni, Safa Bhar Layeb, N. Aissaoui, A. Mannai · 2021 · Managerial and Decision Economics
14. Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study
    R. Ebrahimoghli, A. Janati, H. Sadeghi-Bazargani, H. Hamishehkar, Atefeh Khalili-Azimi · 2021 · Iranian Journal of Medical Sciences
15. Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group
    C. Murley, P. Tinghög, K. Alexanderson, J. Hillert, E. Friberg, K. Karampampa · 2021 · PharmacoEconomics (Auckland)
16. Healthcare utilization and cost outcomes for a multicenter first seizure and new onset epilepsy clinic.
    E. R. Hudson, A. Lesko, Lindsay Lucas, E. Baraban, Evan J Fertig · 2021 · Epilepsy & Behavior
17. Marginal effects and incremental effects in two-part models for endogenous healthcare utilization in health services research
    Xueyan Liu, Wencong Chen, Tian Chen, Hui Zhang, Bo Zhang · 2020 · Health Services & Outcomes Research Methodology
18. The direct and indirect costs of axial spondyloarthritis (axSpA) in Singapore
    Yu H. Kwan, S. Kwoh, J. K. Phang, M. Cheen, K. Lim, C. Wang, Ying-Ying Leung, H. Koh, Truls Østbye, J. Thumboo et al. · 2020 · International Journal of Rheumatic Diseases
19. Outcomes of transcatheter aortic valve implantation for intermediate-risk patients in Australia: the SOLACE-AU trial
    P. Lee, J. Byrnes, M. Mervin, P. Scuffham · 2019 · Journal of Medical Economics
20. The clinical and economic burden of patients with chronic liver disease and thrombocytopaenia receiving platelet transfusions during planned invasive procedures
    Robert S. Brown, R. Bentley, B. Cai, S. Flamm, H. Kanakamedala, J. Lai, S. Marcella, A. Muir, K. Brown · 2019 · GastroHep
21. A Monte Carlo simulation estimating US hospital cost reductions associated with hypotension control in septic ICU patients
    E. Keuffel, M. Stevens, C. Gunnarsson, J. Rizzo, D. Sessler, K. Maheshwari · 2019 · Journal of Medical Economics
22. Case-Mix for Performance Management: A Risk Algorithm Based on ICD-10-CM
    Jian Gao, Eileen Moran, P. Almenoff · 2018 · Medical Care
23. Improving risk equalization for individuals with persistently high costs: Experiences from the Netherlands.
    F. Eijkenaar, R. van Vliet · 2017 · Health Policy
24. Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06).
    K. Matter-Walstra, M. Schwenkglenks, D. Betticher, R. von Moos, D. Dietrich, D. Baertschi, D. Koeberle · 2016 · Clinical colorectal cancer
25. Probabilistic measures of cost‐effectiveness
    I. Bebu, T. Mathew, J. Lachin · 2016 · Statistics in Medicine
26. Methodological developments in randomized controlled trial-based economic evaluations
    J. Thorn, S. Noble, W. Hollingworth · 2014 · Expert review of pharmacoeconomics & outcomes research
27. Use of cognitive enhancers and associated medical care costs among patients with dementia: a nationwide study in Taiwan
    Li‐Jung Elizabeth Ku, Ming‐Chyi Pai · 2014 · International Psychogeriatrics
28. Summaries of articles
    Merima Ali, Abdulaziz B. Shifa, A. Shimeles, F. Woldeyes · 1994 · National tax journal
29. Annual societal cost of Alzheimer’s disease in Malaysia: a micro-costing approach
    Siew Chin Ong, Lyn Xuan Tay, Hui Ming Ong, Ing Khieng Tiong, Alan Swee Hock Ch’ng, Thaigarajan Parumasivam · 2025 · BMC Geriatrics
30. Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases
    G. Torres, Brigitte Alejandra Alarcón, J. Reyes-Sanchez, Natalia Castaño-Gamboa, Giancarlo Buitrago · 2024 · Cost Effectiveness and Resource Allocation
31. Exploring the link between Multimorbidity and direct healthcare costs in Ireland: A cross-sectional study
    Sharon Walsh, Paddy Gillespie · 2023 · Journal of Multimorbidity and Comorbidity
32. Modeling hospitalization medical expenditure of the elderly in China
    Si-Yuan Hao · 2023 · Economic Analysis and Policy
33. Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa
    T. Rautenberg, Shu Kay Angus Ng, Gavin George, M. Moosa, S. McCluskey, R. Gilbert, S. Pillay, I. Aturinda, Kevin L. Ard, W. Muyindike et al. · 2023 · Health and Quality of Life Outcomes
34. Treatment patterns and out-of-hospital healthcare resource utilisation by patients with advanced cancer living with pain: An analysis from the Stop Cancer PAIN trial
    N. McCaffrey, Seong L. Cheah, T. Luckett, J. Phillips, M. Agar, P. Davidson, F. Boyle, T. Shaw, D. Currow, M. Lovell · 2023 · PLoS ONE
35. Association of Cumulative Colorectal Surgery Hospital Costs, Readmissions, and Emergency Department/Observation Stays with Insurance Type
    Michael A. Jacobs, Jasmine C. Tetley, Jeongsoon Kim, Susanne Schmidt, B. Brimhall, V. Mika, Chen-Pin Wang, Laura S. Manuel, Paul Damien, P. Shireman · 2023 · Journal of Gastrointestinal Surgery
36. Performance of administrative database frailty instruments in predicting clinical outcomes and cost for patients undergoing transcatheter aortic valve implantation: a historical cohort study
    Zhe Li, Harindra Channa Wijeysundera, Rodrigo Bagur, Davy Cheng, Janet E Martin, Bob B. Kiaii, Feng Qiu, Jiming Fang, Ava John‐Baptiste · 2022 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
37. Improving risk prediction model quality in the critically ill: data linkage study
    P. Ferrando-Vivas, M. Shankar-Hari, K. Thomas, James C. Doidge, F. Caskey, L. Forni, S. Harris, M. Ostermann, I. Gornik, N. Holman et al. · 2022 · Health and Social Care Delivery Research
38. An integrated primary care-based programme of PRE-Pregnancy cARE to improve pregnancy outcomes in women with type 2 Diabetes (The PREPARED study): protocol for a multi-method study of implementation, system adaptation and performance
    Rita Forde, Olubunmi Abiola, Janet E. Anderson, Debra Bick, Anna Brackenridge, Anita Banerjee, Mark Chamley, Kia‐Chong Chua, Lily Hopkins, Katharine F. Hunt et al. · 2022 · BMC Family Practice
39. The effects of early pregnancy loss on health outcomes and health care utilization and costs
    Erin Strumpf, Nichole Austin, Ariella Lang, Shelley A. Derksen, James M. Bolton, Marni D Brownell, Patricia Gregory, Dan G. Chateau, Maureen I. Heaman · 2022 · Health Services Research
40. Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide
    D. Rana, C. Geue, Kelly Baillie, Jia-Feng Pan, T. Mueller, J. Laskey, M. Bennie, Julie Clarke, Robert J. Jones, Ailsa Brown et al. · 2021 · PharmacoEconomics - Open
41. THE ECONOMIC CONSEQUENCES OF CARDIAC SURGERY ASSOCIATED ACUTE RENAL DYSFUNCTION AFTER HEART SURGERY.
    A. DeAnda, Rituparna Basu, A. Cheung, Andrew D. Shaw · 2020 · Seminars in Thoracic and Cardiovascular Surgery
42. A New Approach to Evaluate Quality Adjusted Life Years using Proxy Utility Function - An Application to HIV/ AIDS Data
    Vishal Deo, Gurprit Grover · 2019 · JOURNAL OF COMMUNICABLE DISEASES
43. Understanding the effect of specialization on hospital performance through knowledge-guided machine learning
    Jangwon Lee, Q. P. He · 2019 · Computers and Chemical Engineering
44. Analysing the Costs of Integrated Care: A Case on Model Selection for Chronic Care Purposes
    M. Carreras, Inma Sánchez-Pérez, P. Ibern, J. Coderch, J. Inoriza · 2016 · International Journal of Integrated Care
45. Cost implications of intraprocedural thrombotic events during PCI
    S. Plent, W. Fan, A. Kirtane, S. Brener, P. Généreux, R. Mehran, Duane S. Pinto, M. McEntegart, David J. Cohen, G. Stone · 2015 · Catheterization and cardiovascular interventions
46. Oral corticosteroid use for clinical and cost-effective symptom relief of sore throat: study protocol for a randomized controlled trial
    J. Cook, G. Hayward, Matthew J. Thompson, Alastair D. Hay, M. Moore, P. Little, Kim Harman, J. Wolstenholme, R. Perera, M. Voysey et al. · 2014 · Trials
47. Associations Between Hemoglobin Level, Resource Use, and Medical Costs in Patients With Heart Failure: Findings From HF-ACTION
    Shelby D. Reed, Yanhong Li, Stephen J. Ellis, John J. Isitt, Sunfa Cheng, Kevin Alan Schulman, David J. Whellan · 2012 · Journal of Cardiac Failure
48. Effects of NCMS Coverage on Access to Care and Financial Protection in China
    Zhiyuan Hou, Ellen Van de Poel, Eddy K.A. van Doorslaer, Baorong Yua, Qingyue Menge · 2012 · SSRN Electronic Journal
49. A Bayesian model averaging approach with non‐informative priors for cost‐effectiveness analyses
    C. Conigliani · 2008 · Statistics in Medicine
50. Sex and Mental Health Disorder Differences Among Military Service Members With Patellofemoral Syndrome
    Daniel I. Rhon, Tanja C. Roy, Robert Oh, Jodi L. Young · 2021 · The Journal of the American Board of Family Medicine
51. Cost-effectiveness analysis of lymphaticovenous anastomosis in reducing cellulitis recurrence in 150 lymphoedema cases followed-up over 24 months.
    I. Humphreys, M. Thomas, C. Pike, K. Morgan, Z. Jessop, T. Bragg, A. Ghattaura · 2025 · Journal of Plastic, Reconstructive & Aesthetic Surgery
52. Age, morbidity, and time to death: End-of-life expenditures on health care for the young-old population
    Irene Torrini, Claudio Lucifora, A. G. Russo · 2025 · European Journal of Health Economics
53. Healthcare Costs of Pressure Injuries among Patients with a Spinal Cord Injury within a Dutch Rehabilitation Center
    Boas J. Wijker, S. de Groot, Anne-Fleur Boertje, J. Adriaansen, W. J. Achterberg-Warmer, Amber Wighman, M. V. van Tulder, Thomas W. J. Janssen, J. V. van Dongen · 2025 · Advances in Skin & Wound Care
54. Health-economic evaluation of orthogeriatric co-management for patients with forearm or humerus fractures: an analysis of insurance claims data from Germany
    E. Henken, H. König, C. Becker, G. Büchele, Thomas Friess, A. Jaensch, K. Rapp, D. Rothenbacher, C. Konnopka · 2024 · BMC Health Services Research
55. Predicting healthcare expenditure based on Adjusted Morbidity Groups to implement a needs-based capitation financing system
    J. Martínez-Pérez, Juan-Antonio Quesada-Torres, Eduardo Martínez-Gabaldón · 2024 · Health Economics Review
56. The Association between Multimorbidity and Out-of-Pocket Expenditures for Prescription Medicines among Adults in Denmark: A Population-Based Register Study
    James Larkin, Susan M. Smith, Line Due Christensen, T. Voss, C. Vestergaard, Amanda Paust, Anders Prior · 2023 · medRxiv
57. Cost-effectiveness of long-term psychoanalytic psychotherapy for treatment-resistant depression: RCT evidence from the Tavistock Adult Depression Study (TADS).
    L. Koeser, Felicitas Rost, A. Gabrio, T. Booker, D. Taylor, P. Fonagy, D. Goldberg, M. Knapp, P. McCrone · 2023 · Journal of Affective Disorders
58. Novel integration of governmental data sources using machine learning to identify super-utilization among U.S. counties
    I. Ricket, Michael E. Matheny, T. A. MacKenzie, Jennifer A. Emond, Kusum L. Ailawadi, Jeremiah R. Brown · 2023 · Intelligent Medicine
59. Work Outcomes and Medical Costs Among Singaporean Adolescent and Young Adult Cancer Survivors
    Chia-Jie Tan, K. Ng, Wei-Lin Goh, E. Poon, R. Chan, L. Chew, M. Farid, A. Chan · 2022 · Journal of Adolescent and Young Adult Oncology
60. Patient and carer access to medicines at end of life: the ActMed mixed-methods study
    S. Latter, N. Campling, J. Birtwistle, A. Richardson, M. Bennett, D. Meads, A. Blenkinsopp, L. Breen, Zoe Edwards, C. Sloan et al. · 2022 · Health and Social Care Delivery Research
61. Costs and 30-day readmission after lower limb fractures from motorcycle crashes in Queensland, Australia: A linked data analysis.
    Samuel Smith, V. McCreanor, K. Watt, M. Hope, Jacelle Warren · 2022 · Injury
62. Can diverse population characteristics be leveraged in a machine learning pipeline to predict resource intensive healthcare utilization among hospital service areas?
    I. Ricket, T. A. MacKenzie, Jennifer A. Emond, Kusum L. Ailawadi, Jeremiah R. Brown · 2022 · BMC Health Services Research
63. Predicting High-risk and High-cost Patients for Proactive Intervention
    Jian Gao, Eileen Moran, D. Higgins, C. Mecher · 2022 · Medical Care
64. Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study.
    N. Vadlamudi, M. Sadatsafavi, D. Patrick, C. Rose, L. Hoang, F. Marra · 2022 · Value in Health
65. Cost-effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan.
    J. Leung, Chih-Wen Chang, A. L. Chan, Hui-Chu Lang · 2022 · Future Oncology
66. Medical expenditure after marginal cut of cash benefit among public assistance recipients in Japan: natural experimental evidence
    D. Nishioka, Reo Takaku, N. Kondo · 2021 · Journal of Epidemiology and Community Health
67. Medical Cost of Cancer Care for Privately Insured Children in Chile
    Florencia Borrescio-Higa, Nieves Valdés · 2021 · International Journal of Environmental Research and Public Health
68. Are spatial models advantageous for predicting county-level HIV epidemiology across the United States?
    Danielle Sass, Bita Fayaz Farkhad, Bo Li, Man-pui Sally Chan, Dolores Albarracín · 2021 · Spatial and Spatio-temporal Epidemiology
69. Absenteeism-Related Wage Loss Associated With Multimorbidity Among Employed Adults in the United States
    R. Mohamed, J. Patel, N. Shaikh, U. Sambamoorthi · 2021 · Journal of Occupational and Environmental Medicine
70. “Willingness to Pay”: The Value Attributed to Program Location by Pulmonary Rehabilitation Participants
    A. Burge, A. Holland, C. McDonald, C. Hill, A. Lee, N. Cox, Rosemary P. Moore, C. Nicolson, P. O'Halloran, Aroub Lahhama et al. · 2021 · COPD
71. Cost-utility analysis of stereotactic body radiotherapy plus cetuximab in previously irradiated recurrent squamous cell carcinoma of the head and neck
    H. Leung, Hui-Chu Lang, shyh-Yau Wang, J. Leung, A. L. Chan · 2021 · Expert review of pharmacoeconomics & outcomes research
72. Cost comparison of two approaches to chiropractic care for patients with acute and sub-acute low Back pain care episodes: a cohort study
    J. Whedon, Serena Bezdjian, Patricia Dennis, Vivi-Ann Fischer, Robb Russell · 2020 · Chiropractic & Manual Therapies
73. Protocol for an economic analysis of the randomised controlled trial of Improving the Well-being of people with Opioid Treated CHronic pain: I-WOTCH Study
    Sheeja Manchira Krishnan, Vijay S. Gc, Harbinder Kaur Sandhu, Martin R Underwood, Sam S. Eldabe, Andrea Manca, Cynthia P Iglesias-Urrutia · 2020 · BMJ Open
74. Trends in Medical Expenditures by Race/Ethnicity in Adults with Type 2 Diabetes 2002 – 2011
    Aprill Z. Dawson, Kinfe G. Bishu, R. Walker, L. Egede · 2020 · Journal of the National Medical Association
75. Factors that Contribute to Cost Differences Based on Intensive Care Unit of Admission in Neonates Undergoing Congenital Heart Surgery: A Novel Decomposition Analysis
    Joyce T. Johnson, K. Sullivan, R. Nelson, X. Sheng, Guo Wei, T. Greene, David K. Bailly, A. Eckhauser, B. Marino, L. Minich et al. · 2020 · Pediatric Critical Care Medicine
76. Case-mix for assessing primary care value (CPCV)
    Jian Gao, Eileen Moran, A. Schwartz, C. Ruser · 2020 · Health Services Management Research
77. The impact of Medicare Part D on opioid use among U.S. older adults.
    Duy Do · 2020 · Drug and Alcohol Dependence
78. Impact of Incident Cancer on Short-Term Coronary Artery Disease–Related Healthcare Expenditures Among Medicare Beneficiaries
    I. Chopra, M. Mattes, P. Findley, Xi Tan, N. Dwibedi, U. Sambamoorthi · 2019 · The Journal of the National Comprehensive Cancer Network
79. Does the Addition of Either a Lateral or Posterior Interbody Device to Posterior Instrumented Lumbar Fusion Decrease Cost Over a 6-Year Period?
    P. Schadler, Peter B. Derman, Lily Lee, H. Do, F. Girardi, F. Cammisa, A. Sama, J. Shue, Stelios Koutsoumbelis, A. Hughes · 2017 · Global Spine Journal
80. A survey of a hurdle model for heavy-tailed data based on the generalized lambda distribution
    Diego Marcondes, C. Peixoto, A. C. Maia · 2017 · Communications in Statistics - Theory and Methods
81. Estimating Dynamic Signals From Trial Data With Censored Values
    Ali Yousefi, Darin Dean Dougherty, Emad N. Eskandar, Alik S. Widge, Uri T. Eden · 2017 · Computational Psychiatry
82. Body weight status and health‐care expenditure among university retirees in Beijing, China
    Ning Jiang, Hong-Jun Yu, R. An · 2017 · Australasian Journal on Ageing
83. Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach
    B. Stollenwerk, T. Welchowski, Matthias Vogl, S. Stock · 2016 · European Journal of Health Economics
84. A comparison of statistical models for analyzing episodes-of-care costs for chronic obstructive pulmonary disease exacerbations
    J. P. Kuwornu, L. Lix, J. Quail, E. Wang, Meriç Osman, G. Teare · 2013 · Health Services & Outcomes Research Methodology
85. Economic burden of asthma multimorbidity in Singapore: Shadow costs of steroid use
    L. Lim, Y. R. Juang, S. Chotirmall, Kelvin Bryan Tan, M. Koh, J. Abisheganaden, D. Price, Ming-Ju Tsai, Mei Fong Liew, P. Y. Tiew et al. · 2025 · The World Allergy Organization Journal
86. Healthcare, caregiver and human capital costs associated with anxiety and depression among Indonesian youths
    Karen Arulsamy, Elmeida Effendy, Sarah A. Mardhiyah, M. M. Amin, M. S. Husada, V. Camellia, Anne-Claire Stona, E. A. Finkelstein · 2025 · BMJ Paediatrics Open
87. Economic burden of moderate and severe anxiety and depression symptoms among adults in Saudi Arabia: evidence from a cross-sectional web panel survey
    Karen Arulsamy, Abdulrahman Alfaisal, J. Puri, Mohammed Alluhidan, Yasmin A. Altwaijri, A. Al-Habeeb, Mariam M. Hamza, V. Çetinkaya, E. Finkelstein · 2025 · BMJ Open
88. Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program
    William H. Herman, Benjamin D. Tyndall, O. Duru, Tannaz Moin, L. McEwen, Hui Shao, Ronald T. Ackermann, Sara R. Jacobs, S. Neuwahl, Shih-Chen Kuo et al. · 2025 · AJPM Focus
89. Signs of Children’s Presence in Two Types of Landscape: Residential and Park: Research on Adults’ Sense of Safety and Preference: Premises for Designing Sustainable Urban Environments
    A. Lis, Karolina Zalewska, Marek Grabowski, Magdalena Zienowicz · 2025 · Sustainability
90. Changes in spending, quality indicators, and provider experiences following the introduction of a population-based payment model in dutch primary care: a mixed methods evaluation
    Tadjo Gigengack, Daniëlle Cattel, F. Eijkenaar · 2025 · European Journal of Health Economics
91. Factors impacting hospitalisation and related health service costs in cancer survivors in Australia: Results from a population data linkage study in Queensland (COS‐Q)
    Katharina M. D. Merollini, Louisa G. Collins, A. Jones, Joanne F Aitken, Michael G. Kimlin · 2024 · Cancer Medicine
92. An economic evaluation of the Prioritising Responses Of Nurses To deteriorating patient Observations (PRONTO) clinical trial.
    S. BohingamuMudiyanselage, Julie Considine, Alison M. Hutchinson, Imogen Mitchell, Mohammadreza Mohebbi, Jennifer J. Watts, Tracey K. Bucknall · 2024 · Resuscitation
93. Is smokeless tobacco use associated with lower health-related quality of life? A cross-sectional survey among women in Bangladesh
    R. Huque, S. M. Abdullah, Sayem Ahmed, Nazmul Hossain, Farhin Islam, M. A. B. Sarker, Md. Nurul Amin, Nasiruddin Ahmed · 2024 · Tobacco Induced Diseases
94. Quantifying the Cost of Shigella Diarrhea in the Enterics for Global Health (EFGH) Shigella Surveillance Study
    Chloe Morozoff, N. Ahmed, Jobiba Chinkhumba, M. Islam, Abdoulie F. Jallow, B. Ogwel, Loyda Fiorella Zegarra Paredes, Doh Sanogo, H. Atlas, H. Badji et al. · 2024 · Open Forum Infectious Diseases
95. Health economic impact of early versus delayed treatment of herpes simplex virus encephalitis in the UK
    S. Defres, Patricia Navvuga, S. Moore, H. Hardwick, A. Easton, B. Michael, R. Kneen, Michael Griffiths, A. Medina-Lara, T. Solomon · 2024 · BMJ Open
96. Retrospective cohort study comparing surgical inpatient charges, total costs, and variable costs as hospital cost savings measures
    Jeongsoon Kim, Michael A. Jacobs, Susanne Schmidt, B. Brimhall, Camerino I. Salazar, Chen-Pin Wang, Zhu Wang, Laura S. Manuel, Paul Damien, P. Shireman · 2022 · Medicine
97. Habitual sleep duration and its relationship with cardiovascular health, healthcare costs, and resource utilization in a working population
    Ehimen C. Aneni, Chukwuemeka U Osondu, Jeffrin Joseph, Gul Jana Saeed, Javier Valero Elizondo, Emir Veledar, Khurram Nasir · 2022 · Sleep Health
98. Direct Medical Costs and Healthcare Resource Utilization of Treating Patients With Two Clinical Subtypes of Axial Spondyloarthritis in Colombia.
    P. Santos-Moreno, Devian Parra-Padilla, Fernando Gómez-De la Rosa, M. Carrasquilla-Sotomayor, L. Villarreal, David Scott Jervis-Jálabe, N. Alvis-Zakzuk · 2022 · Value in Health Regional Issues
99. Promoting benzodiazepine cessation through an electronically-delivered patient self-management intervention (EMPOWER-ED): Randomized controlled trial protocol
    Michael A. Cucciare, H. Hagedorn, M. Bounthavong, Traci H. Abraham, Carolyn J. Greene, X. Han, Lakiesha Kemp, Kathy Marchant, Penny White, K. Humphreys · 2022 · Contemporary Clinical Trials Communications
100. Jointly modeling of sleep variables that are objectively measured by wrist actigraphy
     Xiaonan Xue, Simin Hua, Kathleen M. Weber, Qibin Qi, Robert C. Kaplan, Deborah Gustafson, Anjali Sharma, Audrey L. French, Helen J. Burgess · 2022 · Statistics in Medicine